Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Apollo Endosurgery to Participate in the Cowen Healthcare Conference By: Apollo Endosurgery, Inc. via AccessWire March 02, 2022 at 07:30 AM EST AUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that Chas McKhann, CEO, and Jeff Black, CFO, will host investor meetings March 7-8, 2022 as part of the Cowen Healthcare Conference, taking place virtually.As part of the conference event, management will participate in a fireside chat hosted by Cowen at 12:50 pm Eastern Time on Monday, March 7, 2022. A webcast of the fireside chat will be available on the Investor Relations section of the Apollo Endosurgery website, www.apolloendo.com.For more information about scheduling a one-on-one meeting with management, please contact Matt Kreps, Investor Relations for Apollo Endosurgery, at mkreps@darrowir.com.About Apollo Endosurgery, Inc.Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.Apollo's common stock is traded on NASDAQ Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.Contact:Apollo Endosurgery, Inc.Jeff Black, 512-279-5126investor-relations@apolloendo.comDarrow Associates Investor RelationsMatt Kreps, 214-597-8200mkreps@darrowir.comSOURCE: Apollo Endosurgery, Inc.View source version on accesswire.com: https://www.accesswire.com/691066/Apollo-Endosurgery-to-Participate-in-the-Cowen-Healthcare-Conference Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Apollo Endosurgery to Participate in the Cowen Healthcare Conference By: Apollo Endosurgery, Inc. via AccessWire March 02, 2022 at 07:30 AM EST AUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that Chas McKhann, CEO, and Jeff Black, CFO, will host investor meetings March 7-8, 2022 as part of the Cowen Healthcare Conference, taking place virtually.As part of the conference event, management will participate in a fireside chat hosted by Cowen at 12:50 pm Eastern Time on Monday, March 7, 2022. A webcast of the fireside chat will be available on the Investor Relations section of the Apollo Endosurgery website, www.apolloendo.com.For more information about scheduling a one-on-one meeting with management, please contact Matt Kreps, Investor Relations for Apollo Endosurgery, at mkreps@darrowir.com.About Apollo Endosurgery, Inc.Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.Apollo's common stock is traded on NASDAQ Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.Contact:Apollo Endosurgery, Inc.Jeff Black, 512-279-5126investor-relations@apolloendo.comDarrow Associates Investor RelationsMatt Kreps, 214-597-8200mkreps@darrowir.comSOURCE: Apollo Endosurgery, Inc.View source version on accesswire.com: https://www.accesswire.com/691066/Apollo-Endosurgery-to-Participate-in-the-Cowen-Healthcare-Conference
AUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that Chas McKhann, CEO, and Jeff Black, CFO, will host investor meetings March 7-8, 2022 as part of the Cowen Healthcare Conference, taking place virtually.As part of the conference event, management will participate in a fireside chat hosted by Cowen at 12:50 pm Eastern Time on Monday, March 7, 2022. A webcast of the fireside chat will be available on the Investor Relations section of the Apollo Endosurgery website, www.apolloendo.com.For more information about scheduling a one-on-one meeting with management, please contact Matt Kreps, Investor Relations for Apollo Endosurgery, at mkreps@darrowir.com.About Apollo Endosurgery, Inc.Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.Apollo's common stock is traded on NASDAQ Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.Contact:Apollo Endosurgery, Inc.Jeff Black, 512-279-5126investor-relations@apolloendo.comDarrow Associates Investor RelationsMatt Kreps, 214-597-8200mkreps@darrowir.comSOURCE: Apollo Endosurgery, Inc.View source version on accesswire.com: https://www.accesswire.com/691066/Apollo-Endosurgery-to-Participate-in-the-Cowen-Healthcare-Conference